Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/1999
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999WO1999061041A1 Novel peptides
12/02/1999WO1999061034A1 Improved vectors
12/02/1999WO1999060951A1 Compositions for regenerating tissue that has degenerated, and methods for using such compositions
12/02/1999WO1999060846A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies
12/02/1999WO1999054439B1 Isolation and purging of cells by means of osmotic pressure
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999WO1999035262A3 Apoptosis inducing molecule ii
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999DE19824384A1 Herstellung von Primmorphe·R· aus dissoziierten Zellen von Schwämmen, Korallen und weiteren Invertebraten: Verfahren zur Kultivierung von Zellen von Schwämmen und weiteren Invertebraten zur Produktion und Detektion von bioaktiven Substanzen, zur Detektion von Umweltgiften und zur Kultivierung dieser Tiere in Aquarien und im Freiland Production of Primmorphs · R · from dissociated cells of sponges, corals and other invertebrates: method of culturing cells of sponges and other invertebrates for the production and detection of bioactive substances, for the detection of environmental toxins and for the cultivation of these animals in aquariums and outdoors
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999DE19823834A1 Genetisches Verfahren zur Herstellung von Riboflavin Genetic procedure for the preparation of riboflavin
12/02/1999CA2343317A1 Novel peptides
12/02/1999CA2338344A1 Hematopoietic progenitor cell gene transduction
12/02/1999CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999CA2333702A1 Promotion of cell differentiation by initially passaged cells
12/02/1999CA2333281A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes
12/02/1999CA2333159A1 Method
12/02/1999CA2333006A1 Calmodulin related protein
12/02/1999CA2332336A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies
12/02/1999CA2329694A1 Kunitz domain polypeptide and materials and methods for making it
12/02/1999CA2329513A1 System for reproducing and modulating stability and turnover of rna molecules
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329159A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
12/02/1999CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999CA2328892A1 Tumor suppressor
12/02/1999CA2328525A1 Modification of cereal grain hardness via expression of puroindoline proteins
12/02/1999CA2328524A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999CA2328491A1 Retroviral delivery system
12/02/1999CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999CA2328427A1 Recombinant narbonolide polyketide synthase
12/02/1999CA2328425A1 Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
12/02/1999CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999CA2298064A1 Chimeric adenoviral vectors
12/02/1999CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999EP0960944A1 Enhanced production of taxol and taxanes by cell cultures of taxus species
12/01/1999EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999EP0960339A1 Assay for collagen type ii fragments
12/01/1999EP0960336A1 Peptide reagent for the detection of human cytomegalovirus (cmv)
12/01/1999EP0960209A1 Editing-based selectable plastid marker genes
12/01/1999EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999EP0960203A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
12/01/1999EP0960201A1 Mammalian ribonuclease inhibitors and use thereof
12/01/1999EP0960199A2 Secreted proteins and polynucleotides encoding them
12/01/1999EP0960198A1 Cd44-like protein
12/01/1999EP0960196A1 Novel receptor that causes cell death
12/01/1999EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF
12/01/1999EP0960191A1 Compositions and methods for use of defensin
12/01/1999EP0960190A1 Imidazolinone herbicide resistant sugar beet plants
12/01/1999EP0960130A1 Oxygen-binding heme proteins incorporating circularly-permuted globins
12/01/1999EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999EP0960125A1 GALANIN RECEPTOR GalR2 AND NUCLEOTIDES ENCODING SAME
12/01/1999EP0960123A1 Sprouty protein and coding sequence
12/01/1999EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999EP0960118A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0960114A1 Polymorphisms and new genes in the region of the human hemochromatosis gene
12/01/1999EP0959904A2 Hybrid compositions for intracellular targeting
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959901A1 A method for generating birnavirus from synthetic rna transcripts
12/01/1999EP0959898A1 Lactoferrin variants and uses thereof
12/01/1999EP0959896A2 Human thyrotropin receptor compositions and use thereof
12/01/1999EP0959877A1 Correction of genetic defects using chemical chaperones
12/01/1999CN1237210A Mass production of paclitaxel by changing temp. of medium during plant cell culture
12/01/1999CN1237207A Chrysosporium cellulase and methods of use
11/1999
11/30/1999US5994629 Positive selection
11/30/1999US5994628 Process for protein production in plants
11/30/1999US5994626 Attaching exogenous dna to a carrier particle, accelerating particle at cells of mature cotyledons of alfalfa, culturing tissue on growth promoting media, cultivating into mature plant
11/30/1999US5994624 In planta method for the production of transgenic plants
11/30/1999US5994619 Production of chimeric bovine or porcine animals using cultured inner cell mass cells
11/30/1999US5994527 Fungus-responsive chimeric gene
11/30/1999US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994402 Anti-inflammatory and anti-pyretic method
11/30/1999US5994311 Using a oligopeptides, polypeptide
11/30/1999US5994304 Polypeptide
11/30/1999US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999US5994136 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/30/1999US5994135 Use of 5-bromoindole-3-acetic acid (5-b-iaa) as an auxin affecting plant cell growth; for the regeneration of both plant tissues and transgenic plant tissues
11/30/1999US5994134 Preparing a culture of producer cells coated microcarriers, seeding the bioreactors at high density, increasing infectivity of the producer cells to the virus, culturing the cells under perfusion conditions in serum containing media
11/30/1999US5994133 Perfluorinated polyethers; may be used in the production of comeal implants
11/30/1999US5994132 Adenovirus vectors
11/30/1999US5994128 Primary cells containing a nucleic acid molecule from the adenovirus early genes, eia and eib; an encapsidating signal sequence and an inverted terminal repeat with no overlapping sequences with the target cells; autoimmune disease therapy
11/30/1999US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999US5994126 Obtaining dendritic cell precursors from tissue, culturing on a substrate in medium containing colony stimulating factor to obtain proliferating nonadherent mature cells; therapy for juvenile diabetes, autoimmune diseases, multiple sclerosis
11/30/1999US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999US5994114 A polynucleotide which codes for a protein having taxadiene synthase activity; chemotherapy
11/30/1999US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,